Radiation hybrid mapping of equine CDK2, DGKA, DNAJC14, MMP19, CTSL and GAS1.

The researchers conducted a Radiation Hybrid (RH) mapping of six equine genes. These genes include cyclin-dependent kinase 2 (CDK2), diacylglycerol kinase, alpha 80kDa (DGKA), DnaJ (Hsp40) homolog (DNAJC14), matrix metalloproteinase 19 (MMP19), Cathepsin L (CTSL) and growth arrest-specific 1 (GAS1).

Research Focus

• The study primarily focused on the Radiation Hybrid (RH) mapping of six equine genes namely CDK2, DGKA, DNAJC14, MMP19, CTSL and GAS1.
• Their roles in human health and disease have already been discovered. For instance, CDK2, DGKA DNAJC14 are involved in cell cycle regulation, phosphatidyl-inositols re-synthesis and dopamine receptor expression respectively. On the other hand, MMP19, CTSL and GAS1 are associated with the breakdown of extracellular matrix, protein catabolism and tumor suppression respectively.

Methodology

• The researchers utilized reference human mRNA sequences for CDK2, DGKA, DNAJC14, CTSL and GAS1 to perform BLASTN searches against mammalian expressed sequence tags (ESTs).
• Significant hits were detected in equine ESTs. These ESTs along with the human exon-intron gene structure were then used to design PCR primers for radiation hybrid (RH) mapping of the aforementioned genes.

Radiation Hybrid (RH) mapping

• RH mapping is a method used to help build a comprehensive picture of the genetic architecture of an organism.
• In this context, the method was used to locate and identify the positions of the six studied genes on the equine genome.
• All primer pairs for RH mapping were designed using the Primer3 program.

In summary, the study is part of the wider effort to explore and understand the genetic blueprint of equines. The insights obtained can lead to further investigations, helping to shed light on genetic diseases, breeding strategies, and the physiology of horses in general.